Related Experiment Video
Updated: Jun 11, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Incretin hormones and beta cell function in chronic pancreatitis
1Diabetes Research Division, Department of Internal Medicine F, Gentofte Hospital, University of Copenhagen, Niels Andersens Vej 65, 2900 Hellerup, Denmark. filipknop@dadlnet.dk
The incretin effect, crucial for insulin release, is impaired in type 2 diabetes. This study in chronic pancreatitis patients suggests this impairment is a consequence of diabetes, not its cause, highlighting nutrient assimilation
Area of Science:
- Endocrinology
- Gastroenterology
- Metabolic Diseases
Background:
- Type 2 diabetes mellitus (T2DM) is characterized by a diminished incretin effect, where oral glucose yields a lower insulin response than intravenous glucose.
- The incretin effect is mediated by glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), secreted by the small intestine in response to nutrients.
- The cause of the T2DM incretin defect—whether primary or secondary to the diabetic state—remains unclear.
Purpose of the Study:
- To investigate whether the incretin deficiencies observed in T2DM are a primary cause or a consequence of the diabetic state.
- To examine incretin hormone secretion and effect in patients with chronic pancreatitis (CP) and secondary diabetes mellitus (DM).
Main Methods:
- Studied postprandial incretin responses in patients with CP (with and without pancreatic enzyme supplementation) compared to healthy subjects.
- Assessed the incretin effect in patients with CP and normal glucose tolerance, CP with secondary DM, healthy controls, and T2DM patients.
- Evaluated the insulinotropic effect of incretin hormones in patients with CP and secondary DM compared to controls.
Main Results:
- Pancreatic enzyme supplementation improved postprandial incretin responses in CP patients, indicating nutrient assimilation's role in secretion.
- The incretin effect was preserved in CP patients with normal glucose tolerance but significantly reduced in those with secondary DM.
- Patients with CP and secondary DM showed an impaired insulinotropic effect of GIP, suggesting it's a consequence of the diabetic state.
Conclusions:
- Postprandial incretin hormone secretion is preserved in chronic pancreatitis patients.
- Nutrient assimilation in the small intestine stimulates the secretion of GIP and GLP-1.
- The incretin deficiencies characteristic of T2DM likely arise as a consequence of impaired glucose homeostasis, rather than being a primary etiological factor.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...

